* Merit Medical Systems Inc MMSI.OQ MMSI.O is expected
to show
a rise in quarterly revenue when it reports results on February
22.
* The South Jordan Utah-based company is expected to report
a
4.2% increase in revenue to $290.159 million from $278.49
million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data. The company's guidance on
October 26 2022, for the period ended December 31, was for
revenue between $295.20 million and $300.77 million.
* Refinitiv's mean analyst estimate for Merit Medical
Systems Inc
is for earnings of 67 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Merit
Medical
Systems Inc is $73, above its last closing price of $69.97.
The company's guidance on October 26 2022 for the period ended
December 31 was for gross profit margin between USD44.77% and
USD45.77%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.53 0.53 0.64 Beat 21.1
Jun. 30 2022 0.58 0.58 0.73 Beat 26.3
Mar. 31 2022 0.47 0.47 0.53 Beat 13.9
Dec. 31 2021 0.51 0.52 0.71 Beat 36.5
Sep. 0.44 0.44 0.52 Beat 19.2
30 2021
Jun. 30 2021 0.45 0.44 0.62 Beat 39.7
Mar. 31 2021 0.36 0.36 0.52 Beat 45.4
Dec. 31 2020 0.44 0.43 0.54 Beat 24.3
This summary was machine generated February 21 at 03:01 GMT.
All figures in US dollars unless otherwise stated